Kangdong Liu
Dongshin University(KR)Zhengzhou University(CN)Henan Academy of Sciences(CN)China-US (Henan) Hormel Cancer Institute(CN)Henan Cancer Hospital(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery, PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways
Most-Cited Works
- → Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches(2024)225 cited
- → Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model(2021)89 cited
- → Inflammation in cancer: therapeutic opportunities from new insights(2025)67 cited
- → Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation(2010)67 cited
- → Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2(2012)60 cited
- → Quercetin‐3‐methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways(2018)47 cited